CD8A and neoplasm: In sum, the current literature points towards an association of Tc17 cells with tumor progression in humans, contrary to data generated in mouse models: Transfer of in vitro polarized tumor-reactive Tc17 cells into tumor-bearing mice led to enhanced anti-tumor effects compared to control unpolarized CD8+ T cells.